Elastomeric Infusion Pumps Market worth $1.49 billion by 2030, at a CAGR of 5.3%, says MarketsandMarkets™

Delray Beach, FL, Nov. 28, 2025 (GLOBE NEWSWIRE) -- The Elastomeric Infusion Pumps Market is expected to reach USD 1.49 billion by 2030 from USD 1.15 billion in 2025, at a CAGR of 5.3% during the forecast period, as per the recent study by MarketsandMarkets™. The market for elastomeric infusion pumps is growing steadily due to increased demand for reliable, simple, and efficient drug delivery systems, particularly in the home healthcare and ambulatory care sectors. These pumps provide continuous and accurate medication administration to patients without requiring pre-programming, making them ideal for managing chronic diseases, pain management, and chemotherapy. Patient preferences for self-administration and outpatient care, along with advancements in product designs that are lightweight, simple to use, and single use/disposable, are contributing to growth in the elastomeric infusion pump market. The global aging population, the increased incidence of chronic diseases, and higher healthcare expenditures are contributing to market growth. Regulatory support and new technological advances, including safety features and improvements in elastomeric materials, provide enhanced safety and reliability, leading to improved patient compliance and market expansion across all geographies.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=10422815

Browse in-depth TOC on “Elastomeric Infusion Pumps Market”

280 - Market Data Tables
70 – Figures
330 - Pages

List of Key Players in Elastomeric Infusion Pumps Market:

1. Baxter (US)
2. B. Braun SE (Germany)
3. NIPRO (Japan)
4. AVNS (US)
5. Vygon (France)
6. WOOYOUNG MEDICAL CO., LTD. (South Korea)
7. Shanghai INT Medical Instruments Co., Ltd. (China)
8. Ambu A/S (Denmark)
9. Palex (Spain)
10. DAIKEN MEDICAL CO., LTD. (Japan)

Drivers, Opportunities and Challenges in Elastomeric Infusion Pumps Market:

1. Drivers: Rising Prevalence of Chronic Diseases
2. Restraint: Rising risks of incorrect drug delivery and performance variability
3. Opportunity: Rising healthcare advancements in emerging economies
4. Challenge: Intense competition with electronic infusion technologies

Get Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=10422815

Key Findings of the Study:

• Chemotherapy is expected to be the second-fastest-growing application during the forecast period.
• Ambulatory Surgical Centers (ASCs) are expected to be the second-fastest-growing end-use industry during the forecast period
• North America is expected to be the second-fastest-growing region during the forecast period.

The use of bio-based and sustainable materials for elastomeric infusion pump development is an area of growing interest, aimed at reducing environmental impact while maintaining reliable performance, ensuring drug safety, and ensuring compatibility. Functionalized elastomers, including bioresorbable and recyclable polymers, exhibit improved flowability, chemical stability, and biocompatibility, which are essential for the high viscosity and sensitivity of biologics and other formulations. Sustainable materials and manufacturing methods, such as energy-efficient molding, recycling of single-use devices, or closing the loop on material recovery, lead to environmentally compatible production of elastomeric infusion pumps. The trends toward portable, reliable, and sustainable infusion devices in hospital settings, home healthcare, and in ambulatory care are fostering significant investment from leading medical device companies in developing bio-based elastomers and circular manufacturing processes to meet FDA regulations and ISO 13485 guidelines, as well as environmental considerations, to reduce waste and carbon footprint while prioritizing patient safety.

Based on type, the elastomeric infusion pumps market is segmented into variable-rate and continuous-rate pumps. Continuous-rate pumps accounted for a significant share of the market in 2024 due to their widespread use in hospitals and home-care settings to administer consistent doses of medication over prolonged periods. Continuous Rate pumps are preferred for therapeutic areas including pain management, chemotherapy, and antibiotics requiring drug infusions without complicated adjustments or electronic control.

The elastomeric infusion pumps market has been classified based on end-use industry into hospitals, ambulatory surgical centers, home care settings, and other end users. Hospitals held the largest share in 2024 due to the high volume of inpatient procedures and the growing demand for continuous and controlled drug delivery systems. The elastomeric pumps are often used in hospitals for pain management, chemotherapy, and antibiotic administration, providing a dependable means of infusion without power to enhance patient comfort and safety ultimately. The disposable features and aseptic designs of elastomeric infusion pumps are compatible with hospital infection control measures, reducing contamination and the need to manage equipment. The increased importance placed on efficient postoperative care, along with shorter hospital stays and treatment in the most cost-effective manner, contributes to increased adoption of elastomeric infusion pumps in hospitals.

Get Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=10422815

In 2024, North America represented the predominant segment of the elastomeric infusion pumps market, led by advanced healthcare infrastructure, an increasing number of chronic diseases, and strong utilization of home and ambulatory care. The demand for convenient and affordable drug delivery solutions has led to the increased application of elastomeric pumps in hospitals and outpatient facilities. In the US and Canada, rising incidences of cancer, cardiovascular illnesses, and post-surgical discomfort have augmented the utilization of continuous infusion therapies, including chemotherapy and antibiotic administration. Beneficial reimbursement policies, a robust presence of major manufacturers, and FDA directives enhancing patient safety and quality further facilitate market expansion. As emphasis on patient-centered and value-based care intensifies, North America is projected to maintain its market dominance in the forthcoming years.

The market for elastomeric infusion pumps in the US is growing due to increasing demand for oncology, pain management, and home infusion therapy. These are non-electronic, disposable pumps that can safely deliver medicine 24 hours a day without the need for external power, making them ideal for chemotherapy, antibiotic treatment, and palliative care. Both the U.S. FDA's regulatory control and the CDC's safety recommendations drive compliance with rigorous requirements for infusion-device performance and infection control. Growth is also bolstered by the expansion of CMS home healthcare programs, the increasing adoption of outpatient treatments for chemotherapy-sensitive cancers such as head and neck and colorectal, and the transition to cost-effective, patient-centric care. Greater reliability, infection rates under 0.2%, and high patient preference for mobility continue to drive the adoption of elastomeric pumps in U.S. healthcare environments.  

Market opportunities for elastomeric infusion pumps are growing with the development of biologic therapies, high-viscosity drug products, & digital health technologies. These portable, non-electronic pumps enable the accurate and continuous delivery of high-complexity biologics, such as monoclonal antibodies, in home care or ambulatory settings. The integration of new elastomer chemistries and bioresorbable materials improves precision, flow stability, and compatibility with viscous pharmaceuticals. Recommended by FDA and NIH initiatives that advocate for biologic innovation, together with ISPE’s focus on scalable and sustainable manufacturing, these pumps can enhance therapeutic safety and environmental efficacy. The integration with digital health systems and electronic health records enhances monitoring and precision, establishing elastomeric infusion pumps as vital instruments for safe, efficient, and sustainable drug delivery in oncology, immunotherapy, and the management of chronic illnesses.

Browse Adjacent Markets Equipment Machine and Tooling Market Research Reports & Consulting 

Related Reports:

1. Sterile Medical Packaging Market
2. Protective Packaging Market
3. Building Thermal Insulation Market
4. Silicone Elastomers Market
5. Industrial Lubricants Market

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:

Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445,
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: www.marketsandmarkets.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.